High Prevalence of Diabetes Among Hospitalized COVID-19 Minority Patients: Data from a Single Tertiary Hospital.
Hassan AshktorabGholamreza OskrochiSuryanarayana Reddy ChallaLakshmi G ChirumamillaFaezeh AhangarzadehBoubini Jones-WonniNader ShayeghMudasir RashidZainab NaqviElizabeth EkpeSen SabyasachiAnteneh ZenabeHassan BrimPublished in: Journal of racial and ethnic health disparities (2023)
The prevalence of DM is high among hospitalized COVID-19 patients in our cohort. While DM patients have a higher mortality rate and ICU admission than non-DM patients, other factors such as underlying comorbidities, old age, elevated creatinine, AST, serum inflammatory markers, and D-dimer are more significant predictors of fatal outcomes. DM patients had higher metabolic derangements, hypercoagulability, and severe inflammatory response. No significant difference of outcome was noted between DM patients of different races in our cohort. In the diabetic group, it appears that race may not significantly contribute to the observed mortality disparity. This could be attributed to the significant influence of diabetes, which acts as a major effector, potentially overshadowing the significance of race in this context.
Keyphrases
- end stage renal disease
- chronic kidney disease
- newly diagnosed
- ejection fraction
- inflammatory response
- peritoneal dialysis
- type diabetes
- prognostic factors
- sars cov
- intensive care unit
- risk factors
- adipose tissue
- coronavirus disease
- immune response
- metabolic syndrome
- early onset
- big data
- patient reported
- toll like receptor
- artificial intelligence
- mechanical ventilation